Clinical Trials · NCT04320238
Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Enrollment
- 2,944
- Start date
- Jan 2020
- Locations
- 1 site, China
- Primary endpoint
- new-onset COVID-19